These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 3249455)
21. Urinalysis for detection of chemically induced renal damage (2)--Changes in urinary excretions of enzymes and various components caused by p-aminophenol, puromycin aminonucleoside and hexadimethrine. Ohata H; Momose K; Takahashi A; Omori Y J Toxicol Sci; 1987 Nov; 12(4):357-72. PubMed ID: 3449640 [TBL] [Abstract][Full Text] [Related]
22. Effect of captopril on pre-existing and aminonucleoside-induced proteinuria in spontaneously hypertensive rats. Chiu PJ; Brown AD Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):419-33. PubMed ID: 6454943 [TBL] [Abstract][Full Text] [Related]
23. Glomerular basement membrane heparan sulfate glycosaminoglycan in aminonucleoside of puromycin nephrosis. Garin EH; Shirey AJ Child Nephrol Urol; 1988-1989; 9(3):121-6. PubMed ID: 2978121 [TBL] [Abstract][Full Text] [Related]
24. Ameliorative effects of dietary protein restriction in chronic aminonucleoside nephrosis. Diamond JR; Karnovsky MJ J Lab Clin Med; 1987 May; 109(5):538-44. PubMed ID: 3572200 [TBL] [Abstract][Full Text] [Related]
25. Effect of aminonucleoside nephrosis on immune complex localization in autologous immune complex nephropathy in rats. Couser WG; Jermanovich NB; Belok S; Stilmant MM; Hoyer JR J Clin Invest; 1978 Mar; 61(3):561-72. PubMed ID: 147884 [TBL] [Abstract][Full Text] [Related]
26. Failure of angiotensin converting enzyme inhibition to affect the course of chronic puromycin aminonucleoside nephropathy. Marinides GN; Groggel GC; Cohen AH; Cook T; Baranowski RL; Westenfelder C; Border WA Am J Pathol; 1987 Nov; 129(2):394-401. PubMed ID: 2823616 [TBL] [Abstract][Full Text] [Related]
27. [N-acetyl-beta-D-glucosaminidase (NAG) activity and low molecular weight urinary proteins in rats with puromycin-aminonucleoside (PAN)-induced nephrosis]. Asakura S; Terukina S; Kato K; Taki Y; Asano Y Nihon Jinzo Gakkai Shi; 1987 Nov; 29(11):1443-52. PubMed ID: 3450901 [No Abstract] [Full Text] [Related]
28. Effect of captopril on chronic puromycin aminonucleoside nephrosis in rats. Radin MJ; Wilke WL; Fettman MJ Res Commun Chem Pathol Pharmacol; 1986 Nov; 54(2):279-82. PubMed ID: 3538253 [TBL] [Abstract][Full Text] [Related]
29. [Studies on the evaluation of toxic renal injuries in rats--correlation between urinary enzyme activities and histological changes induced by puromycin aminonucleoside and bis-(2,3-dibromopropyl) phosphate]. Tobe M; Nakaji Y; Korayashi K; Nakamura A; Naitoh K; Saitoh M; Suzuki S; Uchida O; Yasuhara K; Takada K Eisei Shikenjo Hokoku; 1985; (103):51-9. PubMed ID: 3830313 [No Abstract] [Full Text] [Related]
30. Effects of various protein-modifying agents and the aminonucleoside of puromycin on dithioerythritol-reducible disulfide in glomerular basement membrane. Bartlett P; Tu MH; Katona L; Glotzhober D Res Commun Chem Pathol Pharmacol; 1975 Apr; 10(4):673-80. PubMed ID: 1153845 [TBL] [Abstract][Full Text] [Related]
31. Urinary kallikrein in experimental renal disease. Glasser RJ; Michael AF Lab Invest; 1976 Jun; 34(6):616-22. PubMed ID: 933467 [TBL] [Abstract][Full Text] [Related]
32. [Biochemical studies of chemically induced renal damage. I) Changes of urinary enzyme activities induced by puromycin aminonucleoside and mercuric chloride (author's transl)]. Ohno Y; Kawanishi T; Takahashi A; Omori Y Eisei Shikenjo Hokoku; 1979; (97):49-56. PubMed ID: 543958 [No Abstract] [Full Text] [Related]
33. Podocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinol. Ricardo SD; Bertram JF; Ryan GB Exp Nephrol; 1995; 3(5):270-9. PubMed ID: 7583048 [TBL] [Abstract][Full Text] [Related]
34. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside. Grond J; Weening JJ; Elema JD Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809 [TBL] [Abstract][Full Text] [Related]
35. [Follow-up study of glomerular lesions in aminonucleoside nephrosis]. Hirabayashi K; Ishitobi F; Takimoto T; Kure N; Iidaka K Nihon Jinzo Gakkai Shi; 1986 Apr; 28(4):387-400. PubMed ID: 3747250 [No Abstract] [Full Text] [Related]
36. Effects of low protein diet in puromycin aminonucleoside-induced nephrotic rats. Shibasaki T; Gomi H; Ishimoto F; Sakai O Nihon Jinzo Gakkai Shi; 1990 Aug; 32(8):871-5. PubMed ID: 2250404 [TBL] [Abstract][Full Text] [Related]
37. [Protective effect of procyanidolic oligomers on the heterologous phase of glomerulonephritis induced by anti-glomerular basement membrane antibodies]. Melcion C; Verroust P; Baud L; Ardaillou N; Morel-Maroger L; Ardaillou R C R Seances Acad Sci III; 1982 Dec; 295(12):721-6. PubMed ID: 6820305 [TBL] [Abstract][Full Text] [Related]
38. Effect of alterations in glomerular charge on deposition of cationic and anionic antibodies to fixed glomerular antigens in the rat. Adler S; Baker P; Pritzl P; Couser WG J Lab Clin Med; 1985 Jul; 106(1):1-11. PubMed ID: 3891891 [TBL] [Abstract][Full Text] [Related]
39. Protective effects of antithrombin on puromycin aminonucleoside nephrosis in rats. Yamashita J; Nakajima K; Ohno Y; Kaneshiro Y; Matsuo T; Tanaka H; Kaneko K Eur J Pharmacol; 2008 Jul; 589(1-3):239-44. PubMed ID: 18541230 [TBL] [Abstract][Full Text] [Related]
40. Effect of increased glomerular permeability on the localization of immune aggregates and protamine-heparin aggregates in the rat. Weening JJ; Grond J; Hoedemaeker PJ Lab Invest; 1983 Nov; 49(5):619-25. PubMed ID: 6632777 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]